John Pirro
Chief Operational Officer
Long Branch,NJ
Summary
A strategic leader with deep expertise in managing multi-million-dollar budgets, driving sustainable revenue and profitability growth, and conducting financial analysis to optimize organizational performance. Proficiency in research management, clinical trial oversight, and strong communication skills in scientific presentations and written content is an asset in complex, high-stakes environments. Has a talent for innovative problem-solving, cost conservation, and forming strategic alliances. Excels in building and leading high-performing teams while effectively resolving conflicts and driving operational success.
Overview
19
19
years of professional experience
Work History
Chief Scientific Officer
The Hashmi Group
New Delhi
01.2022 - Current
- Assessed founders for Angel investor opportunities, contributing to company valuations exceeding $3M USD.
- Evaluated founders to provide The Hashmi Group's investor network with strategic insights on biotech ventures.
- Enhanced investment strategies by integrating risk assessment, regulatory considerations, and industry trend analysis.
Chief Scientific Officer
Sword Bio
Chicago, Illinois
01.2023 - 01.2025
- Integrated statistical AI software to enhance technology capabilities, increasing capacity by 64%.
- Established and implemented a service delivery model for biotech processes, enhancing workflow efficiency.
- Directed the strategic expansion of molecular and cell-based oncology services, contributing to advancements in diagnostic methodologies.
- Guided strategic development of therapeutic technologies, ensuring alignment with industry standards.
Sr. Director of Operations /Sr. Scientific Advisor
KCAS Bioanalysis and Biomarker Services
Kansas City, Kansas
01.2020 - 01.2023
- Developed and executed financial plans, initially boosting profitability by 41% and ensuring a 15% yearly growth rate.
- Resolved a critical immunological oncology issue for ADC therapeutic, securing FDA approval.
- Demonstrated strong leadership by authoring GLP SOPs that align with new FDA guidelines, ensuring integrity and ethical compliance.
Head of SM and LM Operations (COO)
WuXi AppTec
Plainsboro, New Jersey
01.2018 - 01.2020
- Supervised three staff members in managing small and large molecules, improving efficiency by 56%, and profitability by 31%.
- Spearheaded the expansion of cellular laboratory capabilities by implementing advanced qPCR and ddPCR techniques, elevating the company's role in innovative molecular therapeutic research.
- Managed pivotal change management projects for large and small molecules, refining regulatory services and ensuring seamless communication within cross-functional teams.
Large Molecule Advisor/Sr. Scientific Advisor / Consultant
Independent Consultant
Long Branch, New Jersey
01.2014 - 01.2018
- Guided clients in strategically developing monoclonal antibodies and antibody-drug conjugates using innovative technologies.
- Managed client projects and collaborated with business development for international clients, including Korea.
- Directed risk assessment teams to enhance regulatory immunology processes for clients.
- Oversaw regulatory affairs to ensure compliance and facilitate successful project execution.
General Manager
SGS Life Science Services (CDMO)
Fairfield, New Jersey
01.2011 - 01.2013
- Directed site operations with KPIs and increased capacity by 48%.
- Increased sales by 62% and profitability by 22%.
- Oversaw budgeting for $6.4 million site renovation, achieving completion on schedule.
- Successfully passed FDA inspection, demonstrating a commitment to building under GLP and GMP guidance.
COO/Vice President
Synomics Pharma Services
Wareham, Massachusetts
01.2007 - 01.2011
- Spearheaded strategic molecular and cell-based services initiatives, generating 15% annual revenue growth.
- Collaborated with the management team to implement effective growth strategies.
COO/Vice President of North America
MDS Pharma Services
Montreal, Canada
01.2006 - 01.2007
- Hired to develop a business process for managing FDA regulatory evaluations from 2003 to 2006.
- Facilitated acceptance of 250 generic reports by the FDA, including Clopidogrel, with my name on each.
- Streamlined workflow for re-evaluating all generic drugs requested by the FDA within 7 months.
Education
Bachelor of Science - Cell Biology
University of Iowa
Accomplishments
- Elected Honor Company Leader for CBMU 202 in the Navy Reserve
- By exceeding targets in profitability, I received the highest salary increase for KCAS.
- Received an achievement award and earned the COO leadership position from WuXi AppTech for Leading the redevelopment of Sample receipts, which passed an FDA inspection and increased profits for Large Molecule in 6 months.
- Received an achievement award from SGS for completing the reconstruction of an animal lab to a CDMO facility on time and passing an FDA inspection.
- Received an award from MDS for sending over 250 signed reports to the FDA for the release of Generic drugs to the United States (Framed Clopidogrel report title page sent and approved by FDA)
- Bristol-Myers Squibb presented me with an award and patented my Blood Brain Barrier cellular model for delivery of small molecules into the brain.
Languages
English
Italian
Recommendations
- Don Castle, Senior Vice President of Life Science, SGS Life Sciences, John has demonstrated leadership qualities since our first meeting. He worked for me under very stressful conditions and never gave up. He always thought of his team and direct reports when making difficult decisions. John’s out-of-the-box thinking and leadership made the 100% conversion of 35,000 sqft of lab space into a workable and employee-oriented space. John changed an employee’s culture from acquiesce to a customer-oriented one. John is always open to his team's and upper management's suggestions and opinions. His intelligent way of approaching a problem looks at it from all sides, unique in this industry. He has a good work ethic, and I highly recommend him for a leadership position.
- Stanley Menicherry, Director of DMPK, Bayer Pharmaceuticals, John is the type of person that keeps the big picture in mind. He is results-oriented, Innovative, motivating, and trustworthy, and an exceptional leader, the kind of person others want to emulate. John is always willing to get into the lab to help someone on his team tackle a formidable obstacle. He is one of the smartest guys I know, has an outstanding work ethic, and is an exceptional leader with a natural ability to inspire others. I highly recommend him for a leadership position.
Areas Of Operational Knowledge
- Managing Multi-Million Dollar Budgets
- Achieving Sustainable Revenue & Profitability Growth
- Financial analysis and acumen
- Research management and clinical trial oversight
- Scientific presentations and written communication
- Innovative problem-solving
Key Areas Of Management Competencies
- Institute Cost Conservation Measures
- Multiple Project/Program Management
- Forming Strategic Alliances
- Building & Leading High Performing Teams
- Conflict/Dispute Resolution & Root Cause Analysis
- Effective communication skills
Skills
Clinical trial oversight
Scientific expertise
Budget management
Effective customer communication
Teamwork and collaboration
Excellent communication
Active listening
Work Availability
monday
tuesday
wednesday
thursday
friday
saturday
sunday
morning
afternoon
evening
swipe to browse
Software
Windows Office, Excel, Word, PowerPoint, etc
Work Preference
Work Type
Full TimeWork Location
On-SiteRemoteHybridImportant To Me
Company CultureTeam Building / Company Retreats401k matchStock Options / Equity / Profit SharingAffiliations
- AAPS, GCC, MAHA NJ Coalition, etc.
Interests
Ocean Fishing, Writing Sci Fiction, Golf, Travel internationally
Quote
Writing is a form of therapy; sometimes I wonder how all those who do not write, compose or paint can manage to escape the madness, the melancholia, the panic fear which is inherent in the human situation.
Graham Greene
Timeline
Chief Scientific Officer
Sword Bio
01.2023 - 01.2025
Chief Scientific Officer
The Hashmi Group
01.2022 - Current
Sr. Director of Operations /Sr. Scientific Advisor
KCAS Bioanalysis and Biomarker Services
01.2020 - 01.2023
Head of SM and LM Operations (COO)
WuXi AppTec
01.2018 - 01.2020
Large Molecule Advisor/Sr. Scientific Advisor / Consultant
Independent Consultant
01.2014 - 01.2018
General Manager
SGS Life Science Services (CDMO)
01.2011 - 01.2013
COO/Vice President
Synomics Pharma Services
01.2007 - 01.2011
COO/Vice President of North America
MDS Pharma Services
01.2006 - 01.2007
Bachelor of Science - Cell Biology
University of Iowa
Similar Profiles
John PirroJohn Pirro
Chief Scientific Officer at The Hashmi GroupChief Scientific Officer at The Hashmi Group
Mian Jamal ShahMian Jamal Shah
Operations & Logistics Manager – Laundry Services at Abdulla Mohd S A Al hashmiOperations & Logistics Manager – Laundry Services at Abdulla Mohd S A Al hashmi
SYEDA AIMAN HASHMISYEDA AIMAN HASHMI
Freelance Accountant at Aiman Hashmi ConsultingFreelance Accountant at Aiman Hashmi Consulting
Shania Bland-TurnerShania Bland-Turner
Substitute Teacher at Long Branch Board Of EducationSubstitute Teacher at Long Branch Board Of Education
MaryAnn WoodsMaryAnn Woods
Preschool Ocean Township District Teacher at Acelero LearningPreschool Ocean Township District Teacher at Acelero Learning